iTRAQ: a method to elucidate cellular responses to mycotoxin zearalenone

Area of Science:

• Toxicology
• Proteomics
• Cell Biology

Background:

• Mycotoxin zearalenone (ZEN) contaminates global food and feed supplies.
• ZEN exposure is linked to adverse health effects, including liver, blood, immune, and genetic toxicity.
• Understanding ZEN's cellular mechanisms is crucial for risk assessment.

Purpose of the Study:

• To investigate the cellular response of hepatocarcinoma cells (HepG2) to zearalenone (ZEN) exposure.
• To characterize the proteomic changes induced by ZEN in liver cancer cells.
• To identify specific proteins and pathways affected by ZEN toxicity.

Main Methods:

• Proteomic analysis using isobaric tagging for relative and absolute quantification (iTRAQ).
• Cultured HepG2 cells were treated with 100 µm ZEN for 8 hours.
• Protein identification and quantification via matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).
• Ingenuity pathways analysis (IPA) for biological function and canonical pathway determination.

Main Results:

• Identification and quantification of 982 proteins in ZEN-treated versus control HepG2 cells.
• Differential protein expression patterns were observed in response to ZEN exposure.
• IPA revealed significant alterations in biological functions and canonical pathways related to ZEN toxicity.

Conclusions:

• Proteomic profiling provides insights into the molecular mechanisms of ZEN-induced cellular toxicity.
• ZEN significantly impacts protein expression in HepG2 cells, affecting key biological pathways.
• Further research can utilize these findings to develop strategies for mitigating ZEN's adverse health effects.